Terms: = Uterine cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
49 results:
1. The KRAS, atr and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.
Buchynska L; Gordiienko I; Glushchenko N; Iurchenko N
PLoS One; 2024; 19(4):e0302075. PubMed ID: 38669256
[TBL] [Abstract] [Full Text] [Related]
2. Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer.
Kushwah AS; Masood S; Mishra R; Banerjee M
Crit Rev Oncol Hematol; 2024 Feb; 194():104240. PubMed ID: 38122918
[TBL] [Abstract] [Full Text] [Related]
3. HIV and Early treatment Outcomes Among Women With Cervical cancer Treated With Concurrent Chemoradiation in Tanzania.
Mrema AS; Ngoma M; Josiah C; Lugina E; Mvungi N; Paul M; Mkuchika E; Nundu E; Iddy SK; Rugengamanzi E; Vuhahula YM; Kiwanga FC; Wood C; Mwaiselage J
JCO Glob Oncol; 2023 Sep; 9():e2200441. PubMed ID: 37738537
[TBL] [Abstract] [Full Text] [Related]
4. uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
McNamara B; Harold J; Manavella D; Bellone S; Mutlu L; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MSZ; Yang K; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Burton EA; Inagaki H; Albers A; Zhang C; Bollag G; Schlessinger J; Santin AD
Gynecol Oncol; 2023 May; 172():65-71. PubMed ID: 36958197
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (atr) kinase inhibitor.
Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
[TBL] [Abstract] [Full Text] [Related]
6. Elimusertib (BAY1895344), a novel atr inhibitor, demonstrates in vivo activity in atrX mutated models of uterine leiomyosarcoma.
Harold J; Bellone S; Manavella DD; Mutlu L; McNamara B; Hartwich TMP; Zipponi M; Yang-Hartwich Y; Demirkiran C; Verzosa MS; Choi J; Dong W; Buza N; Hui P; Altwerger G; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2023 Jan; 168():157-165. PubMed ID: 36442427
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania.
Maillie L; Yussuph A; Chirangi B; Schroeder K
Int J Gynaecol Obstet; 2023 Feb; 160(2):604-611. PubMed ID: 36052864
[TBL] [Abstract] [Full Text] [Related]
8. Research Progress in the Relationship Between P2X7R and Cervical cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract] [Full Text] [Related]
9. Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model.
Zhou L; Gu B; Wang J; Liu G; Zhang X
BMC Public Health; 2022 Apr; 22(1):777. PubMed ID: 35436877
[TBL] [Abstract] [Full Text] [Related]
10. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.
Han Y; Bai C; He XM; Ren QL
Purinergic Signal; 2023 Mar; 19(1):145-153. PubMed ID: 35235139
[TBL] [Abstract] [Full Text] [Related]
11. ATARI trial: atr inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI).
Banerjee S; Stewart J; Porta N; Toms C; Leary A; Lheureux S; Khalique S; Tai J; Attygalle A; Vroobel K; Lord CJ; Natrajan R; Bliss J
Int J Gynecol Cancer; 2021 Nov; 31(11):1471-1475. PubMed ID: 34518240
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
Ye S; Wu J; Yao L; He J
J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
[TBL] [Abstract] [Full Text] [Related]
13. Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome.
Wang L; Luo X; Wang Q; Lv Q; Wu P; Liu W; Chen X
J Gynecol Oncol; 2021 Sep; 32(5):e70. PubMed ID: 34132069
[TBL] [Abstract] [Full Text] [Related]
14. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial cancer Recurrence].
Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
[TBL] [Abstract] [Full Text] [Related]
15. Smartphone-Enhanced Training, QA, Monitoring, and Evaluation of a Platform for Secondary Prevention of Cervical cancer: Opportunities and Challenges to Implementation in Tanzania.
Yeates K; Erwin E; Mtema Z; Magoti F; Nkumbugwa S; Yuma S; Hopman WM; Ferguson A; Oneko O; Macheku G; Mtei AF; Smith C; Andrews L; West N; Dalton M; Newcomb A; Ginsburg O
JCO Glob Oncol; 2020 Jul; 6():1114-1123. PubMed ID: 32692627
[TBL] [Abstract] [Full Text] [Related]
16. Digitoxin inhibits HeLa cell growth through the induction of G2/M cell cycle arrest and apoptosis in vitro and in vivo.
Gan H; Qi M; Chan C; Leung P; Ye G; Lei Y; Liu A; Xue F; Liu D; Ye W; Zhang D; Deng L; Chen J
Int J Oncol; 2020 Aug; 57(2):562-573. PubMed ID: 32468057
[TBL] [Abstract] [Full Text] [Related]
17. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on cancer®-accredited facilities.
Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
[TBL] [Abstract] [Full Text] [Related]
18. Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit.
Geary RS; Gurol-Urganci I; Kiran A; Cromwell DA; Bansi-Matharu L; Shakespeare J; Mahmood T; van der Meulen J
BMJ Open; 2019 Feb; 9(2):e024260. PubMed ID: 30782899
[TBL] [Abstract] [Full Text] [Related]
19. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
[TBL] [Abstract] [Full Text] [Related]
20. Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.
Hong S; Xu J; Li Y; Andrade J; Hoover P; Kaminski PJ; Laimins LA
Oncogene; 2019 Apr; 38(17):3274-3287. PubMed ID: 30631149
[TBL] [Abstract] [Full Text] [Related]
[Next]
